Fingerprint
Dive into the research topics of 'Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: A phase I/II trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and efficacy of the SGLT2 inhibitor dapagliflozin in patients with systemic lupus erythematosus: A phase I/II trial
Huijing Wang, Ting Li, Fangfang Sun, Zhe Liu, Danting Zhang, Xiangyu Teng, Laurence Morel, Xiaodong Wang, Shuang Ye
Research output: Contribution to journal › Article › peer-review
30
Scopus
citations